Doctor profile · Federal record

Dr. John Oppenheimer, MD

Allergy Physician (CMS: Allergy/Immunology) · Cedar Knolls, NJ

  • NPI 1639170871
  • Accepts Medicare
  • 40 yrs in practice
  • Male
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
8 Saddle RD, First Floor
Cedar Knolls, NJ 079271902
(908) 934-0555
fax (973) 540-0472
Mailing address
Po Box 416457
Boston, MA 022416457

Credentials & registration

NPPES · NUCC
NPI registered
August 2005 — 21 yrs on file
Profile last updated
May 16, 2016
Year of graduation
1986 — 40 yrs since
Specialty taxonomy
207KA0200X — NUCC code
State license (1)
New Jersey #25MA05056200
Medicaid
NJ #5534500

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1639170871. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
4,512
Distinct HCPCS
9
Medicare allowed
$221,163
HCPCS Description Services Patients Avg allowed
J2357 Injection, omalizumab, 5 mg 2,190 11 $23
95004 Test for allergy using allergenic extract 851 54 $5
J0517 Injection, benralizumab, 1 mg 780 12 $128
99214 Established patient office or other outpatient visit, 30-39 minutes 198 114 $141
99213 Established patient office or other outpatient visit, 20-29 minutes 151 96 $100
94010 Test to measure expiratory airflow and volume 132 71 $9
99204 New patient office or other outpatient visit, 45-59 minutes 105 105 $183
96372 Injection of drug or substance under skin or into muscle 92 27 $16
99203 New patient office or other outpatient visit, 30-44 minutes 13 13 $124

In context: peer comparison

Among 1 peers in this city , average services per provider: 501. This provider delivers 9.0× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$120,023
Transactions
133
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
GlaxoSmithKline, LLC. 82 $77,789.81
GENZYME CORPORATION 7 $16,852.37
AstraZeneca Pharmaceuticals LP 17 $8,696.95
Novartis Pharmaceuticals Corporation 5 $7,188.61
Regeneron Healthcare Solutions, Inc. 4 $5,895.40
Chiesi USA, Inc. 6 $2,396.10
AstraZeneca UK Limited 1 $584.00
Teva Pharmaceuticals USA, Inc. 1 $428.12
Genentech USA, Inc. 2 $56.07
Amgen Inc. 2 $34.00
kaleo, Inc. 2 $29.33
Axsome Therapeutics, Inc. 1 $20.93
Blueprint Medicines Corporation 1 $18.32
Takeda Pharmaceuticals U.S.A., Inc. 1 $17.39
Optinose US, Inc. 1 $15.86

By nature of payment

Consulting Fee
$86,967
Travel and Lodging
$17,678
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
$13,374
Food and Beverage
$2,005

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
781
Patients
253
Total drug cost
$179,013
Drug Type Claims Patients Total cost
Fluticasone Propionate Generic 145 60 $2,389
Montelukast Sodium Generic 127 34 $2,418
Albuterol Sulfate Hfa (Albuterol Sulfate) Brand 70 40 $2,323
Ipratropium Bromide Generic 59 23 $2,294
Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter) Brand 55 17 $61,427
Breo Ellipta (Fluticasone/Vilanterol) Brand 52 13 $35,642
Azelastine Hcl Generic 51 22 $1,708
Epinephrine Generic 39 32 $10,623
Doxepin Hcl Generic 34 0 $1,257
Arnuity Ellipta (Fluticasone Furoate) Brand 32 0 $17,283

Frequently asked questions

Auto-generated from federal data
What is Dr. John Oppenheimer's medical specialty?
Dr. John Oppenheimer practices Allergy Physician in Cedar Knolls, NJ.
Where does Dr. John Oppenheimer practice?
Dr. John Oppenheimer practices at 8 Saddle RD, Cedar Knolls, NJ 079271902. Office phone: 9089340555.
What is Dr. John Oppenheimer's NPI?
Dr. John Oppenheimer's National Provider Identifier (NPI) is 1639170871, issued by NPPES.
Does Dr. John Oppenheimer accept Medicare assignment?
Yes. Dr. John Oppenheimer accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. John Oppenheimer commonly perform?
Top Medicare-reported procedures in 2023: Injection, omalizumab, 5 mg (HCPCS J2357); Test for allergy using allergenic extract (HCPCS 95004); Injection, benralizumab, 1 mg (HCPCS J0517). Source: CMS Medicare Physician & Other Practitioners file.